冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 1 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 2 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - tolterodinum l-tartrat - hart forðahylki - 4 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - ibuprofenum inn - mixtúra, dreifa - 20 mg/ml

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

astrazeneca a/s - budesonidum inn - innöndunarduft - 100 míkróg/skammt

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

astrazeneca a/s - budesonidum inn - innöndunarduft - 200 míkróg/skammt

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

astrazeneca a/s - budesonidum inn - innöndunarduft - 400 míkróg/skammt

欧盟 - 冰岛文 - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.